Latest Releases

If you would like to be alerted when a press release is added to this site, please register with the Alert Service.

Select a Month:
Select a Year:
Search for:
Run your search


Date Title
14/12/2009 Vernalis announces clinical update on partnered compounds AUY922 and HSP990
11/12/2009 Vernalis Earns Milestone Payment in connection with its 2008 sale of Apokyn and its US commercial operations
12/11/2009 Interim Management Statement for the period to 12 November 2009
06/10/2009 Vernalis initiates Pilot Study of V3381 in patients with chronic cough
15/09/2009 Vernalis completes recruitment in V3381 Phase II IN-STEP study for neuropathic pain
06/08/2009 Vernalis and GlaxoSmithKline enter into a collaboration, option and license agreement over a novel Vernalis oncology programme
06/08/2009 Announcement of Interim results for the six months ended 30 June 2009
21/07/2009 Vernalis Announces New Oncology Development Candidate
16/07/2009 Vernalis receives milestone payment in Hsp90 inhibitor collaboration
08/07/2009 Notice of 2009 Half Year Results
Page 1  2    >>